Transforming clinical trials: Episode 3

New Scientist Colab Podcasts
28/02/2024 20 min
Transforming clinical trials: Episode 3

Listen "Transforming clinical trials: Episode 3"

Descargar episodio Ver en sitio original

Episode Synopsis

As the UK transforms its ecosystem for clinical trials, the regulatory landscape is undergoing its biggest change in 20 years. In this third episode of this free New Scientist podcast, we meet Dr Melanie Ivarsson, from the global biotechnology company Moderna, to find out why she chose the UK for a billion-pound research and development program.
 
Sponsored by the UK Department for Business and Trade and the Medicines and Healthcare products Regulatory Agency

Hosted on Acast. See acast.com/privacy for more information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

More episodes of the podcast New Scientist Colab Podcasts

Inside the UK’s Energy Revolution 17/09/2025
A world without dementia? The science and hope ahead 11/09/2025
How Vertex Pharmaceuticals is revolutionising drug discovery 07/09/2025
Women in Science Episode 4: Inside the world of nuclear test monitoring 17/07/2025
Women in Science Episode 3: From the classroom to global defence leader 17/07/2025
Women in Science Episode 2: Challenges of developing a nuclear warhead 19/06/2025
Women In Science Episode 1 : The engineer behind the UK’s nuclear deterrent 19/06/2025
Integrating Scientific Innovation and Health Equity 17/07/2024
Industrial AI and the sustainability revolution - with Pina Schlombs from Siemens 29/05/2024
Transforming clinical trials: Episode 2 21/02/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA